NHS Could Get Groundbreaking Lung Cancer Urine Test in 5 Years

A revolutionary urine test designed to detect lung cancer in its earliest stages could be implemented within the NHS in the next five years. This innovative diagnostic tool, developed by scientists funded by Cancer Research UK, identifies specific 'zombie' cell proteins that are indicative of early-stage lung cancer.

Currently, many lung cancer cases in England are diagnosed at advanced stages, which significantly complicates treatment and reduces survival rates. This new test offers the potential for detection months or even years before symptoms become apparent, marking a significant stride towards improving patient outcomes.

The research, conducted by teams at the University of Cambridge and collaborating institutions, involves a sensor that detects proteins excreted by senescent cells, colloquially known as 'zombie cells.' These cells, while alive, are unable to divide and can contribute to tissue damage and cancer development.

While the sensor has not yet undergone human clinical trials, researchers are optimistic about its potential. Further research is also exploring its applicability to other lung diseases, such as pulmonary fibrosis, and other forms of cancer. The development represents a significant step toward routine early detection in healthcare settings.